Subbarao Jayanthi

Biopharma must step up amidst growing oncology market.

Focusing on prevention, diagnosis, treatment, and care monitoring during the patient journey in oncology to create value for stakeholders.

Examining the current biosimilar market.

A check on the evolving challenges and potential solutions in steering future market adoption of curative-intended treatments.

While gene therapies continue to revolutionize healthcare, uncertainty from commercialization issues still looms large.

Five key areas biopharma manufacturers focus on to predict where the markets will be and determine how standards of care will evolve to effectively position new products.